Significant Number of Biobank Further Contributing to the US Biological Data Visualization Market Growth

Published: Mar 2021

The US biological data visualization market is projected to grow at a significant CAGR during the forecast period (2020-2026). The significant availability of biobanks in the country further raises the demand for biological data visualization tools in the country. The US has a wide number of biobanks such as Biobank Core Facility Phoenix, Institutional Biorepository Core New York, Houston Methodist Research Institute Biorepository Houston, and so on. 

Browse the full report description US Biological Data Visualization Market Size, Share & Trends Analysis Report by Technology (Magnetic Resonance Imaging, Microscopy, Sequencing, and Others), By Application (Genomic Analysis, Cell Biology, Molecular & Structural Analysis, and Others), By End-User ( Pharmaceutical & Biotechnology Companies, Research Institutes, Hospitals, and Clinics) and Forecast 2020-2026 at https://www.omrglobal.com/industry-reports/us-biological-data-visualization-market

These large-scale sample repositories have been developed to collect, analyze and store phenotypic and genetic information based on representative biological samples. Additionally, there are various virtual biobanks to assist investigators to locate biospecimens for testing and analyzing data from multiple biobanks in dispersed locations by using a web portal and software.  

The pharmaceutical and biotechnology companies are actively are considering leveraging the cloud platforms offered by the cloud service providers for the analysis of huge data sets generated at the different stages of the drug development lifecycle ranging from the drug discovery process to the commercialization and marketing of the prepared drug. 

The increasing R&D spending by Lifescience and pharma companies are promoting researches related to gene editing, microbiome testing, and biological sampling among others. A large amount of data is generated during this type of researches which is required to be analyzed insight-fully by segregating the datasets which the researchers to remain competitive among their competitors. The launch of innovative solutions to perform research and commercialization activities of pharma and biotech companies is anticipated to drive the growth of the market.  

    Market Coverage

Report Elements

Details

Study Period

2019-2026

Base year

2019

Forecast period

2020-2026

Segments Covered

By Technology, by Application, and by End-User

Key Companies Profiled

Agilent Technologies, Inc., Becton, Dickinson and Co., Bruker Corp., Danaher Corp., Thermo Fisher Scientific, Inc., Molecular Devices, LLC, and others

Key Questions Addressed by the Report

  • What is the market growth rate during the forecast period?
  • Which segment dominates the market in the base year?
  • Which segment will project the fastest growth in the market during the forecast period?
  • How COVID-19 will impact the market growth in 2020 and the coming years?

o Recovery Timeline

o Deviation from the pre-COVID forecast

o Most affected segment

o Recommendations 

  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

US Biological Data Visualization Market – Segmentation

By Technology

  • Magnetic Resonance Imaging 
  • Microscopy
  • Sequencing  
  • Others (X-ray Crystallography)

By Application

  • Genomic Analysis
  • Cell Biology
  • Molecular and Structural Analysis
  • Others (Alignments, Phylogeny)

By End-User

  • Pharmaceutical & Biotechnology Companies
  • Research Institutes 
  • Hospitals and Clinics

To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/us-biological-data-visualization-market